Multiplex FISH probe sets targeting specific chromosomal regions and gene amplifications commonly altered in tumors. These probes enable detection of genetic abnormalities critical for cancer diagnosis.
Manufactured by
Guangzhou LBP Medicine Science & Technology Co.,Ltd.
China
Guangzhou LBP Medicine Science & Technology Co., Ltd, founded in 2005, is the first publicly listed company in China's pathological diagnosis sector (listed on SSE STAR Market in 2020). The company specializes in R&D and manufacturing of pathological diagnostic products, with core technologies including liquid-based cytology, PCR, FISH probe labeling, and IHC antibody screening. LBP holds 60+ patents including 15 invention patents, with 500+ registered products serving nearly 1,800 medical institutions nationwide. Products are CE certified and approved by BSI and Japan MHLW.
© 2026 Suplivia · Home · Browse Products